Shen Qinghuan gave a brief introduction and showed the test data files to Yu Beiting.

This drug is different from imported special-effect drugs and does not require too many complicated clinical trials.

There are relatively few good drugs on the market at Yu's Medical Research Institute, otherwise Yu Beiting would not have spent a lot of financial and material resources on the hematopoietic function project and would not have spared no effort to invite Dr. "Li ...